UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 341

Sortiert nach

An Examination of the Experiences of Black Football Athletes

Journal of intercollegiate sport, 2019-07, Vol.12 (1), p.73-102

Porter, Jeff

2019

Volltextzugriff (PDF)

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

Nature cell biology, 2012-07, Vol.14 (7), p.717

2012

Volltextzugriff (PDF)

RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation

Molecular cell, 2012-06, Vol.46 (5), p.650-661

2012

Volltextzugriff (PDF)

R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5

PloS one, 2012-07, Vol.7 (7), p.e40976-e40976

2012

Volltextzugriff (PDF)

Annular Flexor Pulley Injuries in Professional Baseball Pitchers: A Case Series

The American journal of sports medicine, 2011-02, Vol.39 (2), p.421-424

2011

Volltextzugriff (PDF)

Shifter: Containers for HPC

Journal of physics. Conference series, 2017-10, Vol.898 (8), p.82021

2017

Volltextzugriff (PDF)

RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation

Molecular cell, 2012-07, Vol.47 (2), p.330-330

2012

Volltextzugriff (PDF)

Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7536-7536

2023

Volltextzugriff (PDF)

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Nature (London), 2012-03, Vol.483 (7391), p.603-607

2012

Volltextzugriff (PDF)

Motivational impact of active learning methods in aerospace engineering students

Acta astronautica, 2019-12, Vol.165, p.344-354

2019

Volltextzugriff (PDF)

Prognostic testing and treatment patterns in Black patients (pts) with chronic lymphocytic leukemia (CLL) from the informCLL prospective, observational registry

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18559-e18559

2022

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7523-7523

2023

Volltextzugriff (PDF)

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity

Cell chemical biology, 2021-06, Vol.28 (6), p.802-812.e6

2021

Volltextzugriff (PDF)

Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e24044-e24044

2021

Volltextzugriff (PDF)

Effects of Thermocapillary and Natural Convection During the Melting of PCMs with a Liquid Bridge Geometry

Microgravity science and technology, 2023-03, Vol.35 (2), p.17, Article 17

2023

Volltextzugriff (PDF)

Efficacy and safety of venetoclax in combination with azacitidine or decitabine in an outpatient setting in patients with untreated acute myeloid leukemia

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7044-7044

2022

Volltextzugriff (PDF)

Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7518-7518

2023

Volltextzugriff (PDF)

BRUIN MCL-321: A phase 3, open-label, randomized study of pirtobrutinib versus investigator choice of BTK inhibitor in patients with previously treated, BTK inhibitor naïve mantle cell lymphoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS7587-TPS7587

2023

Volltextzugriff (PDF)

BRUIN CLL-321: A phase 3 open-label, randomized study of pirtobrutinib versus investigator’s choice of idelalisib plus rituximab or bendamustine plus rituximab in BTK inhibitor pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS7582-TPS7582

2023

Volltextzugriff (PDF)

Samuel Beckett and the Radiophonic Body: Beckett and the BBC

Modern drama, 2010-12, Vol.53 (4), p.431-446

Porter, Jeff

2010

Volltextzugriff (PDF)

Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Nature (London), 2012-12, Vol.492 (7428), p.290-290

2012

Volltextzugriff (PDF)

Preliminary results of the phase 2 study of zanubrutinib in patients with previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19506-e19506

2021

Volltextzugriff (PDF)

Asia subpopulation analysis from the phase III POLARIX trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7558-7558

2022

Volltextzugriff (PDF)

Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7539-7539

2022

Volltextzugriff (PDF)

POLARIX: A phase 3 study of polatuzumab vedotin (pola) plus R-CHP versus R-CHOP in patients (pts) with untreated DLBCL

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS7571-TPS7571

2019

Volltextzugriff (PDF)

1 – 25 von 341

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(305)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(341)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(65)
Humans
(46)
Male
(32)
Physical Sciences
(26)
Female
(24)
Adult
(20)
Biological And Medical Sciences
(19)
Technology
(19)
Animals
(17)
Physics
(17)
Medical Sciences
(16)
Middle Aged
(14)
Exact Sciences And Technology
(13)
Engineering
(12)
Oncology
(12)
Adolescent
(10)
Social Sciences
(10)
Treatment Outcome
(10)
Engineering, Electrical & Electronic
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

An Examination of the Experiences of Black Football Athletes

USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation

R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5

Annular Flexor Pulley Injuries in Professional Baseball Pitchers: A Case Series

Shifter: Containers for HPC

RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation

Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Motivational impact of active learning methods in aerospace engineering students

Prognostic testing and treatment patterns in Black patients (pts) with chronic lymphocytic leukemia (CLL) from the informCLL prospective, observational registry

Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity

Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting

Effects of Thermocapillary and Natural Convection During the Melting of PCMs with a Liquid Bridge Geometry

Efficacy and safety of venetoclax in combination with azacitidine or decitabine in an outpatient setting in patients with untreated acute myeloid leukemia

Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study

BRUIN MCL-321: A phase 3, open-label, randomized study of pirtobrutinib versus investigator choice of BTK inhibitor in patients with previously treated, BTK inhibitor naïve mantle cell lymphoma

BRUIN CLL-321: A phase 3 open-label, randomized study of pirtobrutinib versus investigator’s choice of idelalisib plus rituximab or bendamustine plus rituximab in BTK inhibitor pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Samuel Beckett and the Radiophonic Body: Beckett and the BBC

Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Preliminary results of the phase 2 study of zanubrutinib in patients with previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib

Asia subpopulation analysis from the phase III POLARIX trial

Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN

POLARIX: A phase 3 study of polatuzumab vedotin (pola) plus R-CHP versus R-CHOP in patients (pts) with untreated DLBCL

Suchergebnisse filtern